CEO and President L Daniel Browne sold $180K of Revance Therapeutics, Inc.

Sold$180,068

$15.51Price

11,613Shares

−7%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Mar 18. Filed Tue, Mar 19, 5:01 PM ET, after the close. Not investment advice.